03 · What You Need to Know
The problem is not simply length; it is information design
A three-page consent form can be terrible. A ten-page consent form can be understandable.
Length matters because participants have limited attention and time, but raw page count does not tell you whether information is relevant, comprehensible, prioritized, repetitive, or well organized.
A better question is: does the consent material help participants understand why they might or might not want to participate?
More information does not automatically produce more informed consent
The intuitive model of disclosure is simple: if information is good, more information must be better.
That model eventually breaks down.
When important information competes with large amounts of secondary detail, participants may have greater difficulty identifying what matters. Repetition can make documents longer without making them clearer. Technical completeness can also create the appearance of transparency while leaving the participant with a poor mental model of the study.
This is why current U.S. Common Rule requirements for covered research do not merely require information to be present. Informed consent must begin with a concise and focused presentation of the key information most likely to help a prospective participant understand why they might or might not want to participate. The consent information as a whole must also be organized and presented in a way that facilitates understanding rather than merely providing lists of isolated facts.
Start by distinguishing necessary information from available information
Researchers know far more about their study than participants need in the consent form.
The protocol may contain detailed methodological justification, instrument-development history, statistical plans, operational procedures, monitoring schedules, literature citations, theoretical distinctions, and administrative information.
Those details may be important to the research. That does not make all of them important to the participant's decision.
OHRP's consent-form development checklist specifically encourages researchers to ask what information could affect a person's decision to participate, what context participants need to understand it, and what logistical information may be too detailed and distracting without contributing to informed decision-making.
Necessary consent information
Information required by the governing framework or reasonably important to understanding the study and deciding whether to participate.
Available study information
Everything the research team knows or has documented about the project, much of which may belong in the protocol rather than the participant consent material.
Give the most decision-relevant information prominence
Not every fact deserves equal visual and conceptual weight.
If a study involves an experimental intervention with an important foreseeable risk, that information should not be buried after several pages describing appointment logistics. If participation requires a major time commitment, participants should not have to reconstruct the schedule from scattered paragraphs.
The revised U.S. Common Rule's "key information" requirement reflects this principle for research within its scope. OHRP advisory recommendations identify voluntary participation, purpose, duration, major procedures, reasonably foreseeable risks or discomforts, expected benefits, and appropriate alternatives as topics that may commonly belong among key information, depending on the study.
The exact priorities vary. The important point is that consent should have an information hierarchy.
Do not confuse "key information" with "the only information"
Prioritization does not authorize researchers to delete required content.
The key-information section is intended to orient the participant to the most consequential features of the decision. Additional information may still be necessary elsewhere in the consent material.
A concise opening therefore works best as an entry point rather than a substitute for adequate disclosure.
Some complexity belongs in the consent form
Researchers should resist the opposite mistake: deciding that anything difficult should be removed because it might overwhelm participants.
If a complicated feature could materially affect the decision, participants need an understandable explanation of it.
Randomization, placebo use, uncertain risks, genomic analysis, future use of specimens, data sharing, limits to confidentiality, research-related costs, or complicated withdrawal consequences can be difficult concepts. Difficulty is a reason to communicate them better, not necessarily a reason to omit them.
The relevant question is whether the information is necessary, not whether it is convenient to explain.
Repetition is a common source of unnecessary length
Consent forms can become long because the same idea appears in slightly different language across multiple sections.
Voluntariness might be stated in the introduction, again under risks, again under withdrawal, and again above the signature. Confidentiality language may repeat what has already been explained without adding useful detail.
Some repetition can reinforce especially important information. Mechanical repetition usually adds pages rather than understanding.
During editing, ask whether each repeated statement performs a distinct communication function.
Administrative detail can crowd out participant information
Research teams naturally care about operational details because those details keep the study running. Participants may not need all of them.
For example, participants may need to know that they will attend three visits lasting approximately one hour each. They may not need an exhaustive description of internal scheduling procedures, staff handoffs, database labels, or administrative workflow.
OHRP's current consent-form checklist explicitly encourages researchers to identify logistical information that may be too detailed and distracting without contributing to an informed participation decision.
That is a useful editing test: does this detail help the participant decide or act, or does it mainly document how the research team operates?
Rare risks need proportionate communication
Risk disclosure can become especially difficult when researchers try to be exhaustive.
Participants need appropriate information about reasonably foreseeable risks and discomforts under major ethical and regulatory frameworks. But presenting every risk with identical emphasis can make it harder to distinguish common minor discomforts from uncommon but serious consequences.
Where the evidence permits, useful risk communication may distinguish risks by nature, seriousness, likelihood, reversibility, or other characteristics relevant to the decision. Researchers should avoid false precision when reliable frequencies are not known.
Long risk lists are not automatically more transparent if participants cannot interpret what matters.
Layering can manage complexity without hiding information
One useful approach is to structure information in layers.
The participant first encounters the most decision-relevant information. More detailed explanations then appear in logical sections where they can be reviewed as needed.
Electronic consent can extend this approach through expandable definitions, optional explanatory material, multimedia, or navigation that allows participants to move backward and forward. Joint FDA and OHRP guidance advises that electronic consent systems should be easy to navigate and allow users to review information appropriately.
Layering should improve navigation, not conceal required information behind interfaces participants are unlikely to discover.
The participant population changes what counts as too much
Information burden is contextual.
A document designed for specialists participating in professional research may reasonably use terminology that would be inappropriate for a general community sample. Participants considering a complex clinical trial may need substantially more information than people considering a brief minimal-risk questionnaire.
Language proficiency, literacy, age, familiarity with research, cognitive demands, and accessibility needs can also affect how much information participants can realistically process and how it should be presented.
This is why simplifying participant information without losing what matters is more sophisticated than merely shortening sentences.
Readability and length measure different things
A short document can still be unreadable. A longer document can use excellent plain language and organization.
Readability formulas may help identify difficult sentence structures or vocabulary, but they do not measure conceptual load, relevance, information hierarchy, or whether participants can identify the implications of participation.
Page count has the same limitation. It tells you how much space the document occupies, not how effectively it communicates.
There is no defensible universal maximum
Researchers sometimes want a number: five pages, 2,000 words, ten minutes of reading.
No universal threshold can sensibly accommodate both a brief anonymous questionnaire and a complex longitudinal clinical investigation.
Some institutions, ethics committees, funders, or study types may impose templates or expectations, and those should be followed where applicable. But researchers should not turn a local formatting convention into a universal ethical principle.
Watch Out
Do not solve information overload by deleting required or materially important information. First remove redundancy, irrelevant protocol detail, avoidable jargon, and poor organization. If the consent remains long because the decision is genuinely complex, the appropriate response may be better communication rather than artificial brevity.
